August 2025
1. MA Y, Ye C, Khalil AM, Mahmoud SH, et al
   A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.
   J Virol. 2025 Aug 7:e0082125. doi: 10.1128/jvi.00821.
   

   >> Share

   
   April 2025
2. HUANG Y, Liang G, Wang T, Ma Y, et al
   Research strategies of the N-peptide fusion inhibitor: a promising direction for discovering novel antivirals.
   J Virol. 2025 Apr 10:e0228924. doi: 10.1128/jvi.02289.
   

   >> Share

   
   March 2025
3. CHATTERJEE D, Niu L, Medjahed H, Ding S, et al
   A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120.
   J Virol. 2025 Mar 27:e0226724. doi: 10.1128/jvi.02267.
   

   >> Share

   
   January 2025
4. FEDORCHENKO SV, Klimenko Z, Martynovich T, Solianyk I, et al
   Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks.
   J Virol. 2025 Jan 22:e0184324. doi: 10.1128/jvi.01843.
   

   >> Share

   
   
5. COHEN P, Lambson BE, Mkhize NN, Moodley C, et al
   Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance.
   J Virol. 2025 Jan 16:e0173024. doi: 10.1128/jvi.01730.
   

   >> Share

   
   
6. ARORA P, Zhang L, Nehlmeier I, Kempf A, et al
   Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
   J Virol. 2025 Jan 10:e0123024. doi: 10.1128/jvi.01230.
   

   >> Share

   
   June 2024
7. LI S, Wei B, Xu L, Cong C, et al
   In vivo efficacy of phage cocktails against carbapenem resistance Acinetobacter baumannii in the rat pneumonia model.
   J Virol. 2024 Jun 12:e0046724. doi: 10.1128/jvi.00467.
   

   >> Share

   
   May 2024
8. DEKKER JG, Klaver B, Berkhout B, Das AT, et al
   Reverse transcription of HIV-1 2-LTR circle transcripts does frequently cause 3'-polypurine tract mutations implicated in dolutegravir resistance.
   J Virol. 2024 May 24:e0033524. doi: 10.1128/jvi.00335.
   

   >> Share

   
   February 2024
9. HAN P, Lin W, Fan H, Tong Y, et al
   Characterization of phage evolution and phage resistance in drug-resistant Stenotrophomonas maltophilia.
   J Virol. 2024;98:e0124923.
   

   >> Share

   
   January 2024
10. TAN X, Chen K, Jiang Z, Liu Z, et al
    Evaluation of the impact of repeated intravenous phage doses on mammalian host-phage interactions.
    J Virol. 2024;98:e0135923.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share